Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (2) | Back to Search
Synthesis and characterisation of sterically hindered pyridine based multinuclear platinum anticancer complexes and their cytotoxicity
- In: Posters C - Drug Design and Discovery
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PC-024
- By: APPS, Michael G. (The University of Sydney, Faculty of Pharmacy, Camperdown, Australia)
- Co-author(s): Ammit, Alaina J. (The University of Sydney, Camperdown, Australia)
Wheate, Nial J. (The University of Sydney, Camperdown, Australia) - Abstract:
I. Background
Multinuclear platinum drugs, such as BBR3464, are of current interest due to their higher activity compared to cisplatin and their retained activity in cisplatin resistant cells. They are however extremely toxic and susceptible to degradation. A current drug undergoing clinical trials, picoplatin, has a sterically hindered platinum.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023